Episode 11_Dr. Chad Beyer

Chad E. Beyer, PhD, MBA. Dr. Beyer is the President & CEO of Promentis Pharmaceuticals (www.promentispharma.com).  He is also a father, golfer, skier, assistant hockey coach and scientific professional with more than 15 years of experience in the development of medications designed to treat brain disorders.   Prior to joining Promentis, Dr. Beyer worked in the Discovery Neuroscience group at Wyeth Pharmaceuticals. He held positions with increasing responsibility including serving as the Head of Neurochemistry and leading the Psychiatry Task Force. During his career at Wyeth, Dr. Beyer managed several drug discovery teams, contributed to the submission of more than 30 INDs and provided supporting data for the commercialization and life-cycle management of Effexor® and Pristiq® -- two blockbuster antidepressants. Dr. Beyer’s research career began at the National Institutes of Health in NIDA’s Addiction Research Center and he subsequently received a PhD in Neuropharmacology from LSU Medical Center and an MBA from the Rutgers Business School. Notably, Chad has authored more than 70 manuscripts, 5 patents, is the co-editor of a psychiatry review book, is co-founder of the journal "Technology Transfer & Entrepreneurship” and is an adjunct faculty member at Thomas Jefferson University. This Spotlight Conversation was recorded and conducted by Dr. Brian Postdoc @ThePostdocWay on October 2013.